Capital Research Global Investors
ADNT icon

Capital Research Global Investors’s Adient ADNT Stock Holding History

Capital Research Global Investors’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-802,301
Closed -$29.4M – 409
2023
Q3 		$29.4M Hold
802,301
– – 0.01% 352
2023
Q2 		$30.7M Hold
802,301
– – 0.01% 348
2023
Q1 		$32.9M Hold
802,301
– – 0.01% 352
2022
Q4 		$27.8M Buy
802,301
+134,046
+20% +$4.69M 0.01% 368
2022
Q3 		$18.5M Buy
668,255
+166,955
+33% +$5.42M 0.01% 366
2022
Q2 		$14.9M Buy
501,300
+86,850
+21% +$2.92M ﹤0.01% 393
2022
Q1 		$16.9M Buy
+414,450
New +$17.8M ﹤0.01% 407

Other funds holding ADNT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Capital Research Global Investors's ADNT Position: Q4 2023 in Review

Capital Research Global Investors sold out of Adient (ADNT) in Q4 2023, closing a stake of 802,301 shares — an estimated $29.4M sold.

Capital Research Global Investors first reported a position in ADNT in Q1 2022 and held it in 7 quarters. The position peaked at $32.9M in Q1 2023. 303 funds tracked by Wall St. Rank hold ADNT as of Q4 2023.

  • Capital Research Global Investors reported no remaining Adient position as of Q4 2023 after selling out during the quarter.
  • Capital Research Global Investors sold 802,301 Adient shares in Q4 2023, an estimated $29.4M.
  • Capital Research Global Investors first reported a position in Adient in Q1 2022 and held it in 7 quarters.
  • Capital Research Global Investors's Adient position peaked at $32.9M in Q1 2023.
  • 303 funds tracked by Wall St. Rank held Adient as of Q4 2023.

Based on Capital Research Global Investors's 13F filing for Q4 2023, filed 13 Feb 2024.